Back to Authors

Bergsagel, Peter Leif

Mayo Clinic

a Division of Hematology/Oncology , Mayo Clinic , Phoenix , AZ , USA.

Citations 1

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Leukemia & Lymphoma | January 11, 2018 | Volume: 59 | Issue: 9 | Pages: 2128-2134

10.1080/10428194.2017.1416368 | PMID 29320913